• Forskolin in cAMP Assays and Stem Cell Workflows

  2026-09-23

  Use Forskolin to probe adenylate-cyclase–cAMP signaling in cell assays, with practical guidance for stock preparation, dose selection, and troubleshooting. The article also separates established Forskolin use-cases from a retinal ganglion cell differentiation study whose reproducibility lessons are useful—but which did not test Forskolin.

• Bleomycin Sulfate: DNA Damage & Fibrosis Workflows

  2026-09-23

  Build reproducible DNA-damage assays and pulmonary fibrosis models with Bleomycin Sulfate, from concentration scouting to pathway-level validation. This guide connects practical bench workflows with mitochondrial injury, PINK1/Parkin mitophagy, and TGF-β/Smad signaling readouts.

• Dextromethorphan Hydrobromide in Neuroprotection

  2026-09-22

  A translational framework for using dextromethorphan hydrobromide as an NMDA receptor antagonist and ion-channel probe in excitotoxicity, neuroprotection, cerebral ischemia, and Alzheimer’s disease research, with practical guidance on assay design, mechanism deconvolution, product selection, and evidence boundaries.

• OM-MSCs, Golgi Stress, and PI3K/Akt/mTOR

  2026-09-22

  This study identifies a paracrine mechanism by which olfactory mucosa mesenchymal stem cells reduce Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its integrated cell and rat models connect PEDF secretion with PI3K/Akt/mTOR signaling, reduced oxidative and calcium stress, and suppression of excessive autophagy.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-21

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) supports reproducible HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is a research-use reagent only, with no directly matched paper evidence supplied here, and should not be used for diagnostic, therapeutic, or medical applications.

• HyperFluor™ 488 Rabbit Anti-Goat IgG for FXR Imaging

  2026-09-21

  Translate FXR–replication organelle biology into sharper fluorescence, Western blot, flow cytometry, and tissue-staining readouts. This Alexa Fluor 488 conjugated secondary antibody combines goat-primary compatibility with practical optimization guidance for spatial and quantitative assay workflows.

• EZ Cap™ Cas9 mRNA (m1Ψ) for CRISPR Editing

  2026-09-20

  EZ Cap™ Cas9 mRNA (m1Ψ) is an in vitro transcribed mRNA with Cap1 structure, m1Ψ substitution, and a poly(A) tail for Cas9 delivery. Its design supports mRNA stability and translation efficiency while providing a transient research format for CRISPR-Cas9 genome editing.

• BCL-XL inhibitor A-1155463: Workflow Guide

  2026-09-19

  Build apoptosis experiments around a selective BCL-XL inhibitor that distinguishes BCL-XL-dependent cells from less-dependent controls. This practical guide covers dosing, mechanistic validation, resistance models, sequential pathway studies, and troubleshooting for translational cancer research.

• Docosahexaenoic Acid: Assay-to-Insight Framework

  2026-09-18

  Docosahexaenoic Acid (DHA) is more than a neuroactive lipid: it is an experimental variable whose effects depend on membrane context, oxidation state, and assay design. This evidence-centered framework connects DHA neuroprotection research with lessons from a recent arachidonic acid immunology study while defining the limits of cross-domain interpretation.

• SP2509 for Reliable AML Epigenetics

  2026-09-18

  This scenario-based guide explains how SP2509 (SKU B4894) can support interpretable viability, proliferation, and cytotoxicity workflows in acute myeloid leukemia research. It connects LSD1 mechanism, compound handling, assay controls, data interpretation, and practical vendor-selection criteria without equating biochemical potency with cellular response.

• FXR Phase Separation Clusters Coronavirus Replication Organe

  2026-09-17

  Li et al. identify fragile X–related proteins as host factors that organize β-coronavirus double-membrane vesicles through liquid–liquid phase separation. The study connects FXR-dependent replication-organelle clustering with local translation and SARS-CoV-2 replication, while providing a framework for imaging and perturbation-based follow-up experiments.

• Phosphatase Inhibitor Cocktail 1: Signal Fidelity

  2026-09-17

  Phosphatase Inhibitor Cocktail 1 preserves labile phosphorylation signals during sample preparation. This article connects its component-level inhibition strategy with multi-omic oncology workflows and practical decisions for Western blotting, immunoprecipitation, and phosphoproteomic analysis.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-09-16

  Translate goat-primary immunodetection into bright, flexible readouts for immunofluorescence, Western blotting, flow cytometry, and tissue staining. This guide shows how to use an Alexa Fluor 488 conjugated secondary antibody to interrogate FXR-associated replication-organelle organization while controlling background, photobleaching, and cross-assay variability.

• Meropenem Workflows for Infection Models

  2026-09-16

  Meropenem provides a practical broad-spectrum benchmark for Gram-negative and Gram-positive infection studies, resistance profiling, and septicemia treatment research. This guide translates β-lactam pharmacology into reproducible susceptibility, time-kill, and infection-model workflows while highlighting formulation, stability, and interpretation limits.

• Docosahexaenoic Acid: Research Workflows

  2026-09-15

  Build reproducible DHA experiments for neuronal, retinal, and oxidative-stress models with practical handling guidance and assay checkpoints. The article also separates DHA neurobiology from arachidonic-acid vaccine findings, helping researchers translate lipid-signaling insights without overstating the evidence.

8536 records 1/570 page Next 12345 下5页 Last page